MEDBRIGHT AI INVTS INC (MBAIF)
| Previous close | 0.0680 |
| Open | 0.0740 |
| Bid | 0.0480 x 0 |
| Ask | 0.0830 x 0 |
| Day's range | 0.0740 - 0.0740 |
| 52-week range | 0.0012 - 0.2893 |
| Volume | |
| Avg. volume | 16,095 |
| Market cap | 7.715M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireMedBright AI Announces Strategic Acquisition by Numinus Wellness
Plans name change to “Numinus Intelligence” leveraging its current revenue generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright’s AI-enabled clinical solution capabilities with Numinus’ deep data and vast experience with drug-assisted mental health treatment to improve clinical operations and capitalize on reimbursable offeringsLeaders from MedBright AI team with extensive experience in US healthcare clinic operations and ownership pla
PR NewswireNuminus Wellness Announces Strategic Acquisition of MedBright AI
Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces execution of a letter of intent (the "LOI") to acquire MedBright AI Investments Inc. ("MedBright AI") (CSE: MBAI) by way of a statutory plan of arrangement (the "Proposed Transaction").
- GlobeNewswire
MedBright AI Announces New Commercial Product Demos for MedMatrix AI Platform
VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) today announced MedMatrix, a product in which it has a significant investment, has launched two new demonstration videos highlighting the capabilities of the MedMatrix AI Reporter and Forecaster. The videos highlight the key product areas of the MedMatrix Reporter and Forecaster to provide a birds-eye view of clinic operations, including insi
